Publications 2024

Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
J Neurooncol, 169 (1), 137-145
DOI 10.1007/s11060-024-04709-z, PubMed 38762830

Cameron AL, Mandeville H, Coppadoro B, Periasamy M, Davila Fajardo R, Ferrari A, Gaze MN, Helfre S, Magelssen H, Minard-Colin V, Ramos M, Schoot R, Zanetti I, Bisogno G, Chisholm JC, Merks JHM (2024)
The Impact of Radiation Therapy on Metastatic Rhabdomyosarcoma: Results From the EpSSG MTS 2008 Study
Int J Radiat Oncol Biol Phys (in press)
DOI 10.1016/j.ijrobp.2024.08.039, PubMed 39222824

Dávila Fajardo R, Scarzello G, Gaze MN, Boterberg T, Cameron A, Fuchs J, Guérin F, Hoskin P, Krasin MJ, Kroon P, Magelssen H, Mercke C, Merks JHM, Paulsen F, Pommier P, Ramos M, Rees H, Rogers T, Schmid M, Seitz G, Slater O, Smeulders N, Stenman J, Terwisscha S, Chargari C et al. (2024)
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines
Radiother Oncol, 195, 110273
DOI 10.1016/j.radonc.2024.110273, PubMed 38588921

Østergaard DE, Embring A, Sehested A, Magelssen H, Vogelius IR, Kjærsgaard M, Nysom K, Mathiasen R, Lukacova S, Maraldo MV (2024)
REMIT: Reirradiation of Diffuse Midline Glioma Patients -A Nordic Society of Paediatric Haematology and Oncology Feasibility Study
Clin Oncol (R Coll Radiol), 37, 103682 (in press)
DOI 10.1016/j.clon.2024.103682, PubMed 39626445

Publications 2023

Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
Neurooncol Pract, 11 (1), 36-45
DOI 10.1093/nop/npad063, PubMed 38222046

Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
BMJ Open, 13 (3), e070071
DOI 10.1136/bmjopen-2022-070071, PubMed 36940951

Jesse S, Kuhlmann L, Hildebrand LS, Magelssen H, Schmaus M, Timmermann B, Andres S, Fietkau R, Distel LV (2023)
Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
Cells, 12 (5)
DOI 10.3390/cells12050820, PubMed 36899955

Leske H, Blakstad H, Lund-Iversen M, Skovholt EK, Niehusmann P, Ramm-Pettersen JT, Skogen K, Kongelf G, Sprauten M, Magelssen H, Brandal P (2023)
Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A
Neuropathology, 43 (5), 385-390
DOI 10.1111/neup.12895, PubMed 36754566

Turcas A, Kelly SM, Bernier-Chastagner V, Bolle S, Cameron A, Corning C, Clementel E, Dieckmann K, Davila Fajardo R, Gaze MN, Laprie A, Magelssen H, Meroni S, Pignoli E, Safwat A, Scarzello G, Talbot J, Timmermann B, Boterberg T, Mandeville HC (2023)
Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience
Radiother Oncol, 187, 109810
DOI 10.1016/j.radonc.2023.109810, PubMed 37468069

Werlenius K, Kinhult S, Solheim TS, Magelssen H, Löfgren D, Mudaisi M, Hylin S, Bartek J, Strandéus M, Lindskog M, Rashid HB, Carstam L, Gulati S, Solheim O, Bartek J, Salvesen Ø, Jakola AS (2023)
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
JAMA Netw Open, 6 (3), e234149
DOI 10.1001/jamanetworkopen.2023.4149, PubMed 37000452

Publications 2021

Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Mandeville H, Boterberg T, Kroon PS, Kotte ANTJ, Hoeben BAW, van Rossum PSN, van Grotel M, Graf N, van den Heuvel-Eibrink MM, Rübe C, Janssens GO (2021)
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise
Clin Transl Radiat Oncol, 28, 39-47
DOI 10.1016/j.ctro.2021.03.001, PubMed 33796796

Switlyk MD, Niehusmann P, Sprauten M, Magelssen H, Aarhus M, Rasmussen FØ, Knutstad K, Brandal P (2021)
Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge
Acta Radiol Open, 10 (7), 20584601211036550
DOI 10.1177/20584601211036550, PubMed 34377543

Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM et al. (2021)
Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
Acta Oncol, 61 (2), 235-238
DOI 10.1080/0284186X.2021.2022202, PubMed 34970940

Publications 2020

Janssens GO, Melchior P, Mul J, Saunders D, Bolle S, Cameron AL, Claude L, Gurtner K, van de Ven KP, van Grotel M, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Muracciole X, Boterberg T, Mandeville H, Godzinski J, Graf N, van den Heuvel-Eibrink MM, Rübe C (2020)
The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy
Lancet Child Adolesc Health, 4 (11), 846-852
DOI 10.1016/S2352-4642(20)30183-8, PubMed 33068550

Publications 2019

Hoeben BA, Carrie C, Timmermann B, Mandeville HC, Gandola L, Dieckmann K, Ramos Albiac M, Magelssen H, Lassen-Ramshad Y, Ondrová B, Ajithkumar T, Alapetite C, Balgobind BV, Bolle S, Cameron AL, Davila Fajardo R, Dietzsch S, Dumont Lecomte D, van den Heuvel-Eibrink MM, Kortmann RD, Laprie A, Melchior P, Padovani L, Rombi B, Scarzello G et al. (2019)
Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
Lancet Oncol, 20 (3), e155-e166
DOI 10.1016/S1470-2045(19)30034-8, PubMed 30842059

Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
Acta Oncol, 58 (10), 1416-1422
DOI 10.1080/0284186X.2019.1643496, PubMed 31364899

Publications 2018

Ajithkumar T, Horan G, Padovani L, Thorp N, Timmermann B, Alapetite C, Gandola L, Ramos M, Van Beek K, Christiaens M, Lassen-Ramshad Y, Magelssen H, Nilsson K, Saran F, Rombi B, Kortmann R, Janssens GO, SIOPE BTG Radiotherapy Group (2018)
SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy
Radiother Oncol, 128 (2), 192-197
DOI 10.1016/j.radonc.2018.04.016, PubMed 29729847

Seravalli E, Bosman M, Lassen-Ramshad Y, Vestergaard A, Oldenburger F, Visser J, Koutsouveli E, Paraskevopoulou C, Horan G, Ajithkumar T, Timmermann B, Fuentes CS, Whitfield G, Marchant T, Padovani L, Garnier E, Gandola L, Meroni S, Hoeben BAW, Kusters M, Alapetite C, Losa S, Goudjil F, Magelssen H, Evensen ME et al. (2018)
Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group)
Acta Oncol, 57 (9), 1240-1249
DOI 10.1080/0284186X.2018.1465588, PubMed 29698060

Publications 2011

Stensvold E, Magelssen H, Oskam IC (2011)
Fertility-preserving measures for girls and young women with cancer
Tidsskr Nor Laegeforen, 131 (15), 1429-32
DOI 10.4045/tidsskr.11.0126, PubMed 21844944

Stensvold E, Magelssen H, Oskam IC (2011)
Fertility-preserving measures for boys and young men with cancer
Tidsskr Nor Laegeforen, 131 (15), 1433-5
DOI 10.4045/tidsskr.11.0426, PubMed 21844945

Publications 2008

Cvancarova M, Samuelsen SO, Magelssen H, Fosså SD (2008)
Reproduction rates after cancer treatment: experience from the Norwegian radium hospital
J Clin Oncol, 27 (3), 334-43
DOI 10.1200/JCO.2007.15.3130, PubMed 19075285

Kiserud CE, Magelssen H, Fedorcsak P, Fosså SD (2008)
[Gonadal function after cancer treatment in adult men]
Tidsskr Nor Laegeforen, 128 (4), 461-5
PubMed 18274582

Magelssen H (2008)
Reproduction and pregnancy outcome in cancer survivors
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 637, 1 b. (flere pag.)
BIBSYS 081071523, ISBN 978-82-8072-465-6

Publications 2007

Magelssen H, Melve KK, Skjaerven R, Fosså SD (2007)
Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood
Hum Reprod, 23 (1), 178-86
DOI 10.1093/humrep/dem362, PubMed 18024486

Publications 2006

Magelssen H, Brydøy M, Fosså SD (2006)
The effects of cancer and cancer treatments on male reproductive function
Nat Clin Pract Urol, 3 (6), 312-22
DOI 10.1038/ncpuro0508, PubMed 16763643

Publications 2005

Fosså SD, Magelssen H, Melve K, Jacobsen AB, Langmark F, Skjaerven R (2005)
Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report
J Natl Cancer Inst Monogr (34), 77-82
DOI 10.1093/jncimonographs/lgi019, PubMed 15784830

Magelssen H, Haugen TB, von Düring V, Melve KK, Sandstad B, Fosså SD (2005)
Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?
Eur Urol, 48 (5), 779-85
DOI 10.1016/j.eururo.2005.05.002, PubMed 15963629

Publications 2004

Fosså SD, Magelssen H (2004)
Fertility and reproduction after chemotherapy of adult cancer patients: malignant lymphoma and testicular cancer
Ann Oncol, 15 Suppl 4, iv259-65
DOI 10.1093/annonc/mdh936, PubMed 15477318